In one paragraphArticle in Molecular cancer research : MCR, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors at 1 institution in 3 countries.
Ahmed Rokan *Department of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0003-0140-9353 Juan Carlos Hernandez *Department of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0001-5264-9184 Rajeshwar NitiyanandanDepartment of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0003-0972-741X Zi-Ying LinDepartment of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0001-8825-6139 Chia-Lin ChenDepartment of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0003-4798-6199 Tatsuya MachidaDepartment of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0001-9694-3879 Meng LiNorris Medical Library, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0001-6063-4855 Jasleen KhanujaDepartment of Pathology, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0002-7645-3167 Mo Li ChenNorris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0001-5777-2501 Stanley M TaharaDepartment of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0001-5097-0927 Imran SiddiqiDepartment of Pathology, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0001-8083-9639 Keigo MachidaDepartment of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, California.ORCID 0000-0002-9721-8553 University of Southern California · US
Funding
The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8MUSC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OOKHTENS, MURAD · 1995 to 2020
$21.8MNON-PARENCHYMAL LIVER CELL CORER24AA012885 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TSUKAMOTO, HIDEKAZU · 2001 to 2025
$8.1MNANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCVR01AA025204 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MACHIDA, KEIGO · 2017 to 2021
$1.9MNanog-positive cancer stem cells in and liver oncogenesis by alcohol and HCVR01AA018857 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MACHIDA, KEIGO · 2009 to 2013
$1.8MLncRNA with MSI2 and super-enhancer in liver cancer stem cells induced by alcoholR21AA025470 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MACHIDA, KEIGO · 2018 to 2019
$444kConfocal Microscopy Imaging SystemS10RR022508 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OOKHTENS, MURAD · 2007 to 2007
$415kNCRR NIH HHS S10 RR022508NIAAA NIH HHS P50 AA011999NIAAA NIH HHS R01 AA018857NIAAA NIH HHS R01 AA025204NIAAA NIH HHS R21 AA025470NIAAA NIH HHS R24 AA012885NIDDK NIH HHS P30 DK048522
6 · The paper itselfAbstract
Synergism between obesity and virus infection promotes the development of B-cell lymphoma. In this study, we tested whether obesity-associated endotoxin release induced activation-induced cytidine deaminase (AID). TLR4 activation in turn caused c-JUN-dependent and STAT3-dependent translocations of MYC loci to suppress transactivation of CD95/FAS. We used viral nucleocapside Core transgenic (Tg) mice fed alcohol Western diet to determine whether oncogenesis arising from obesity and chronic virus infection occurred through TLR4-c-JUN-STAT3 pathways. Our results showed B cell-specific, c-Jun and/or Stat3 disruption reduced the incidence of splenomegaly in these mice. AID-dependent t(8;14) translocation was observed between the Ig promoter and MYC loci. Comparison with human B cells showed MYC-immunoglobulin (Ig) translocations after virus infection with lipopolysaccharide stimulation. Accordingly, human patients with lymphoma with virus infections and obesity showed a 40% incidence of MYC-Ig translocations. Thus, obesity and virus infection promote AID-mediated translocation between the Ig promoter and MYC through the TLR4-c-JUN axis, resulting in lymphoproliferation. Taken together, preventative treatment targeting either c-JUN and/or STAT3 may be effective strategies to prevent tumor development. IMPLICATIONS: Obesity increases gut-derived endotoxin which induces Toll-like receptor-mediated MYC-Ig translocation via c-JUN-STAT3, leading to lymphoproliferation.
Indexed as
EndotoxinsToll-Like Receptor 4AnimalsB-LymphocytesHumansImmunoglobulinsMiceMice, TransgenicSTAT3 Transcription FactorTranslocation, GeneticEndotoxinsImmunoglobulinsSTAT3 protein, humanSTAT3 Transcription FactorTLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4
Identifiers
PMID36287175
PMCPMC9898117
OpenAlexW4307344214
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390